eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Pochopień,Michał;Cherney,David;Kerstin Folkerts, MSc;Levy,Pierre;Millier,Aurélie;Morris,Stephen;Roy-Chaudhury,Prabir;Sean D. Sullivan, PhD;Paul Mernagh, MCom;

Publication

Article

December 8, 2021

Supplements and Featured Publications

Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone

Volume27

Issue 20

eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Author(s):

Michał Pochopień, MSc,David Z. I. Cherney, MD, PhD

Supplementary Appendix

Download PDF

Download Issue PDF

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions

eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Newsletter